MedPath

PTASEZ capsule

Registration Number: MAL16085004NC

Approved
Approval ID

1528d28e1d7af5c1

Registration Number

MAL16085004NC

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types5 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (5)

30capsule CapsulesAvailable
Package Size: 30capsule Capsules
Status: NPRA Approved
45capsule CapsulesAvailable
Package Size: 45capsule Capsules
Status: NPRA Approved
60capsule CapsulesAvailable
Package Size: 60capsule Capsules
Status: NPRA Approved
90capsule CapsulesAvailable
Package Size: 90capsule Capsules
Status: NPRA Approved
120capsule CapsulesAvailable
Package Size: 120capsule Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (3)

L-ARGININEActive
Monograph: L-arginine
EURYCOMA LONGIFOLIA EXTRACT (TONGKAT ALI)Active
Monograph: eurycoma longifolia extract (tongkat ali)
PINE BARK EXTRACT (PINUS PINASTER)Active
Monograph: pine bark extract (pinus pinaster)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PTASEZ capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform